UMass Medical School depression expert Anthony Rothschild, MD, is conducting a clinical trial of ketamine for patients with treatment-resistant depression.
Javier Elbio Irazoqui, PhD, associate professor of microbiology & physiological systems, is interested in fundamental mechanisms of innate immunity and inflammation.
Health care reform may now lay with states, which can use federal waivers to change the Affordable Care Act and Medicaid with less fanfare than efforts that originate in Washington, D.C., according to UMass Medical School health care law and policy expert Rachel Gershon, JD, MPH, in an opinion piece for STAT.
Mark D. Johnson, MD, PhD, chair and professor of neurosurgery, studies normal pressure hydrocephalus (NPH), and is focused on developing a simple, readily accessible test to identify patients who have it.
In this Expert's Corner video, Neil Aronin, MD, professor of medicine, co-director of the Neurotherapeutics Institute and a globally recognized leader in the field, talks about exploring a promising new therapeutic approach to Huntington's disease based on gene silencing or RNA interference.
Chancellor Michael F. Collins told the Worcester Business Journal Economic Forecast Forum on Thursday, Feb. 16, of his concern that the National Institutes of Health funding—critical to UMass Medical School as well as the local economy and the future of science and medicine nationwide—could suffer under the Trump administration.